Inventor · disambiguated record
Marie-Pierre Dube
Also filed as: DUBE MARIE-PIERRE · DUBÉ MARIE-PIERRE
9 granted patents·7 pending applications·49 citations·filing 2003–2022
85Inventor score
Files withHOFFMANN LA ROCHE7DALCOR PHARMA UK LTD LEATHERHEAD ZUG BRANCH3BESSETTE LUC1DALCOR PHARMA UK LTD STOCKPORT ZUG BRANCH1DUBE MARIE-PIERRE1
Top patents by PatentIndex Score
16 records- 0188US10711303B2CETP inhibitors for therapeutic useHOFFMANN LA ROCHE·Filed 2018·Granted Jul 14, 2020·3 cites·12 claims
- 0285US9909178B2Dalcetrapib for therapeutic useHOFFMANN LA ROCHE·Filed 2015·Granted Mar 6, 2018·5 cites·15 claims
- 0384US7734656B2System and method for electronically managing medical data files in order to facilitate genetic researchBESSETTE LUC·Filed 2004·Granted Jun 8, 2010·37 cites·20 claims
- 0482US11401554B2Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agentHOFFMANN LA ROCHE·Filed 2020·Granted Aug 2, 2022·1 cites·13 claims
- 0582US10584385B2Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agentHOFFMANN LA ROCHE·Filed 2017·Granted Mar 10, 2020·3 cites·20 claims
- 0677US12371748B2Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agentHOFFMANN LA ROCHE·Filed 2022·Granted Jul 29, 2025·0 cites·12 claims
- 0767US11549142B2CETP inhibitors for therapeutic useHOFFMANN LA ROCHE·Filed 2020·Granted Jan 10, 2023·0 cites·10 claims
- 0856US2018155784A1Cetp inhibitors for therapeutic useHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 0955US2021290623A1Methods for treating or preventing cardiovascular disorders and lowering risk of cardiovascular eventsDALCOR PHARMA UK LTD LEATHERHEAD ZUG BRANCH·Filed 2021·Application pending·0 cites
- 1053US2019070178A1Methods for treating or preventing cardiovascular disorders and lowering risk of cardiovascular eventsDALCOR PHARMA UK LTD STOCKPORT ZUG BRANCH·Filed 2018·Application pending·0 cites
- 1152US2016230231A1Genotyping tests and methods for evaluating plasma creatine kinase levelsINST DE CARDIOLOGIE DE MONTREAL·Filed 2014·Application pending·0 cites
- 1251US2020222406A1Methods for treating or preventing cardiovascular disorders and lowering risk of cardiovascular eventsDALCOR PHARMA UK LTD LEATHERHEAD ZUG BRANCH·Filed 2020·Application pending·0 cites
- 1350US2021236442A1Methods for delaying occurrence of new-onset type 2 diabetes and for slowing progression of and treating type 2 diabetesDALCOR PHARMA UK LTD LEATHERHEAD ZUG BRANCH·Filed 2021·Application pending·0 cites
- 1441US8334369B2Mutations in human UBIAD1SAMUELS MARK ELLIOT·Filed 2008·Granted Dec 18, 2012·0 cites·15 claims
- 1540US2006166207A1Hsan II related gene and expression products and uses thereofLAFRENIERE RONALD G·Filed 2003·Application pending·0 cites
- 1630US8563241B2Genetic predictors of international normalized ratio (INR) fluctuation with warfarin therapyDUBE MARIE-PIERRE·Filed 2010·Granted Oct 22, 2013·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Marie-Pierre Dube files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →